During the past decade, Kalmar Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kalmar Hospital" #1 sponsor was "Karolinska Institutet" with 2 trials, followed by "Fresenius Medical Care Deutschland GmbH" with 1 trials sponsored, "Johnny Ludvigsson" with 1 trials sponsored, "Sahlgrenska University Hospital, Sweden" with 1 trials sponsored and "Sangart" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kalmar Hospital" #1 collaborator was "Centrallasarettet Västerås" with 2 trials as a collaborator, "Karolinska University Hospital" with 2 trials as a collaborator, "Uppsala University" with 2 trials as a collaborator, "Uppsala University Hospital" with 2 trials as a collaborator and "Diamyd Medical AB" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Kalmar Hospital" are "Breast Cancer" (1 trials), "Chronic Renal Failure" (1 trials), "Diabetes Mellitus, Type 1" (1 trials), "Femoral Neck Fractures" (1 trials) and "Hypotension" (1 trials). Many other conditions were trialed in "Kalmar Hospital" in a lesser frequency.

Most popular intervention types in "Kalmar Hospital" are "Drug" (3 trials), "Other" (3 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arthroplasty" (1 trials), "Exercise-based cardiac rehabilitation" (1 trials), "GAD-Alum (Diamyd) 20 µg" (1 trials), "GAD-Alum (Diamyd) 20 µg X 2" (1 trials) and "Hemospan (MP4OX)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kalmar Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Kalmar Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kalmar Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kalmar Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".